Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesShould vardenafil be used for the treatment of lower urinary tract symptoms associated with BPH
NCP Urology, 08/20/08
Te AE et al. - This study demonstrates that vardenafil is a promising treatment for symptoms secondary to BPH, including LUTS and ED, further studies are needed before phosphodiesterase type 5 inhibitors become a treatment for LUTS associated with BPH.
Related Articles
Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms
Internet Source, 11/23/09
Relevance Score: 82%%
The Influence of Psychiatric Comorbidities and Sexual Trauma on Lower Urinary Tract Symptoms in Female Veterans
The Journal of Urology, 11/23/09
Relevance Score: 82%%
Lower urinary tract dysfunction in MS: management in the community
British Journal of Community Nursing, 11/17/09
Relevance Score: 81%%
Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study
World Journal of Urology, 11/13/09
Relevance Score: 81%%
Is ultrasound estimation of bladder weight a useful tool in the assessment of patients with lower urinary tract symptoms
International Urogynecology Journal, 10/07/09
Relevance Score: 81%%
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Predicting Recurrence and Progression of Noninvasive Papillary Bladder Cancer at Initial Presentation Based on Quantitative Gene Expression Profiles
European Urology, 11/30/09
Bacillus Calmette-Gurin Is Superior to a Combination of Epirubicin and Interferon-2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study
European Urology, 11/30/09
What is the Optimal Treatment Strategy for T1 Bladder Tumors
European Urology, 11/30/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life
Prostate Cancer & Prostatic Diseases, 11/30/09
The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
European Urology, 11/30/09
Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer
Annals of Oncology, 11/24/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Ultrasonic sonoporation can enhance the prostate permeability
Medical Hypotheses, 11/30/09
Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer
The Prostate, 11/30/09
Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life
Prostate Cancer & Prostatic Diseases, 11/30/09
Article Search
Sponsor